The Active Pharmaceutical Ingredient (API) industry plays a crucial role in the global healthcare ecosystem. APIs are the biologically active components of pharmaceutical drugs, responsible for their therapeutic effects. The development, manufacturing, and distribution of APIs are critical to ensuring the availability of effective medications for a wide range of diseases and conditions. As the pharmaceutical industry continues to evolve, the API sector faces numerous challenges and opportunities that shape its future.
Sevoflurane is well-tolerated by patients, with a lower incidence of adverse respiratory and cardiovascular effects compared to other volatile anesthetics. This characteristic makes it suitable for patients with compromised respiratory function or those who are prone to hypotension. Moreover, sevoflurane’s non-irritating properties allow for smoother induction, reducing the incidence of agitation and distress during mask induction, a common concern in children.